DNL
Diurnal Group plc
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers an oral formulation of hydrocortisone granules in capsules for the treatment of pediatric adrenal insufficiency.
Similar securities
Based on sector and market capitalization
Report issue